Lunai Bioworks (LNAI) Stock: Buy, Sell, or Hold?
LNAI - Lunai Bioworks Inc. Common Stock
$1.30
-0.08 (-5.80%)
▼
5d:
-32.64%
30d:
-45.83%
90d:
-57.93%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 13, 2026
Get Alerted When LNAI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: LNAI is down 32.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: LNAI is down 32.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: LNAI is currently trading at $1.30, which is considered oversold relative to its 30-day fair value range of $1.81 to $2.48.
Technical Outlook: Technically, LNAI is showing sideways momentum. Immediate support is located at $1.23, while resistance sits at $2.67. Short-term momentum is weak, with the stock down 5.8% recently.
Market Sentiment: LNAI scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LNAI is showing sideways momentum. Immediate support is located at $1.23, while resistance sits at $2.67. Short-term momentum is weak, with the stock down 5.8% recently.
Market Sentiment: LNAI scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.81 -
$2.48
Company Quality Score
34/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
47.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.8%)
- WARNING: Composite score 34/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.81 -
$2.48
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.23
Resistance Level
$2.67
Current Trend
Sideways
Technical data as of
Oct 2, 2026
Fundamental Context
Share & Embed Analysis
Last updated: October 05, 2026 6:00 AM ET
Data refreshes hourly during market hours. Next update: 7:00 AM
Data refreshes hourly during market hours. Next update: 7:00 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LNAI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
23 analysts |
$84 | 71 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
15 analysts |
$52 | 66 BUY |
|
ABVX
Abivax SA American Depos… |
STRONG BUY
12 analysts |
$164 | 67 BUY |
|
TSHA
Taysha Gene Therapies Inc |
STRONG BUY
13 analysts |
$13 | 59 HOLD |